Routine ECGs should be used as a scalable first-pass triage step to identify patients who should undergo echocardiography for reduced ejection fraction across diverse patient populations, and beat-level attention maps provided interpretability into the model's predictions.
Abstract
Reduced left ventricular ejection fraction (LVEF) is frequently asymptomatic and often detected only after advanced heart failure develops. Electrocardiograms are recorded routinely yet underused for this condition, because reduced LVEF has no single diagnostic waveform. We trained an ensemble of vision transformers from scratch to detect reduced LVEF ($\leq$40%) from 12-lead ECGs, analyzing each heartbeat individually, using 10,142 patients across seven sites in three US health systems. In a held-out external cohort of 4,092 patients from three geographically independent US clinical sites at a real-world reduced-LVEF prevalence of 8.72%, the model achieved an AUROC of 0.88 (95% CI 0.86-0.89), sensitivity 81.2%, specificity 81.0%, and negative predictive value 97.8%. Sensitivity remained high across sex, race, ethnicity, and comorbidity subgroups, while specificity was lower in older patients and those with atrial fibrillation or cardiomyopathy. Beat-level attention maps provided interpretability into the model's predictions, showing consistent focus on the QRS complex rather than the P wave. These findings support the potential of routine ECGs as a scalable first-pass triage step to identify patients who should undergo echocardiography for reduced ejection fraction across diverse patient populations.
In this single-center exploratory cohort of patients with obstructive hypertrophic cardiomyopathy receiving mavacamten, ECG-Vision left ventricular demonstrated high observed sensitivity and negative predictive value for TTE-defined LVSD, although estimates were imprecise because LVSD events were infrequent.
Aakash Bavishi, John Fritzlen, Marybeth Soutar et al.· Circulation: Heart Failure· 0 citations
Adding AI-ECG signals to PREVENT-HF improves near-term heart-failure risk discrimination and reclassification, though without demonstrated benefit on clinical outcomes such as heart-failure hospitalization or mortality.
A. Bollmann, V. Pradler, D. Husser et al.· Frontiers in Cardiovascular...· 0 citations
Artificial intelligence-enhanced electrocardiography demonstrated good diagnostic performance for detecting LVDD and may support future rule-out or risk-enrichment strategies in selected populations, however, current evidence remains insufficient to support routine clinical implementation.
Johann A. C. Edjimbi, Nisarg Shah, L. Donisi et al.· European Heart Journal - Dig...· 1 citation
In this retrospective cohort and using the current AI-ECG model, BAV detection showed modest diagnostic performance and limited standalone clinical utility, suggesting that ECG-only screening for BAV may require additional modalities or more refined phenotyping.
Manuel A. Montoya-Hernández, Francisco López-Jiménez, T. Poterucha et al.· Journal of the Heart Valve S...· 0 citations
ABSTRACT The electrocardiogram (ECG) is a low‐cost, readily available test that may detect dysrhythmia, chamber enlargement, and ischemia in an acquired heart disease population. Use of resting ECG to predict adverse events in an adult congenital heart disease (ACHD) population is unknown. ECG characteristics, outcomes...
S. S. Mousavi, C. Raskind-Hood, A. Haffner et al.· Annals of Noninvasive Electr...· 1 citation
It is suggested that ECG models for systolic HF can be developed using ICD-based labels from routine clinical data, with model output associated with echo-derived LVEF, however, the performance decrease in external evaluation underscores the importance of careful interpretation and validation against imaging-derived en...
L. Graf, G. Riedemann, N. Spicher et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.